BCL2 and cancer: The BH3 motif of the anti-apoptotic Bcl-2 proteins is central to their function, and is the key to drug development strategies aimed at inhibiting anti-apoptotic Bcl-2 family members as a means to re-activate the intrinsic apoptotic pathway in cancer cells.